Presence of MGD has minimal effect on ocular surface in medically treated glaucoma

No additional effect on ocular surface parameters was seen in patients with medically treated glaucoma with or without meibomian gland dysfunction, according to a study.The cross-sectional study included 70 patients with glaucoma on long-term (longer than 1 year) topical hypotensive medications. Meibomian gland dysfunction (MGD) is “frequently encountered” in these patients, according to the researchers, with mild to moderate disease detected in 47 of the 70 patients and minimal signs detected in nine.

Full Story →